Reversal by L-cysteine of the growth inhibitory and glutathione-depleting effects of N-methylformamide and N,N-dimethylformamide.
N-Methylformamide and N,N-dimethylformamide, which can induce differentiation in selected malignant cell lines, are known to increase doubling times, inhibit clonigenicity in agar, and to effect responses against particular human colon carcinomas in vivo. At concentrations which inhibit growth and clonigenicity, N-methylformamide (170 mM) and N,N-dimethylformamide (103 mM) deplete total intracellular glutathione levels of DLD-1 Clone A human colon carcinoma cells in a dose and time dependent manner. In the presence of 0.5 mM 1-cysteine, both the growth and glutathione levels of polar-solvent treated DLD-1 Clone A cells are restored. 1-Cysteine also reverses the inhibition of clonigenicity mediated by NMF. The mechanism of action of N-methylformamide and N,N-dimethylformamide against this cell line, at least in vitro, is therefore related to its effects on cysteine/glutathione metabolism. Furthermore, this evidence suggests that glutathione plays a key role in regulating the growth of these cells.
D000970:Antineoplastic Agents / Q000633:toxicity*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002999:Clone Cells; D003110:Colonic Neoplasms / Q000503:physiopathology; D003545:Cysteine / Q000494:pharmacology*; D004126:Dimethylformamide / Q000633:toxicity*; D004336:Drug Antagonism; D005559:Formamides / Q000633:toxicity*; D005978:Glutathione / Q000378:metabolism*; D006801:Humans
D000970:Antineoplastic Agents; D005559:Formamides; D004126:Dimethylformamide; D005978:Glutathione; D003545:Cysteine; C002950:methylformamide